Hepatitis Australia is using new data released from the Kirby Institute today showing only one per cent of people with hep C received treatment last year to push the government to list new hep C drugs without delay. “It’s time for action,” said Kevin Marriott, Hepatitis Australia Acting CEO. “It’s time of the federal government […]
